Silver HK - Search Results

1

Adjuvant BCG immunotherapy for stage I and II malignant melanoma.

Silver HK, Ibrahim EM, Evers JA, Thomas JW, Murray RN, Spinelli JJ. Silver HK, et al. Can Med Assoc J. 1983 Jun 1;128(11):1291-5. Can Med Assoc J. 1983. PMID: 6342739 Free PMC article. Clinical Trial.

2

Prediction of malignant melanoma recurrence by serum N-acetylneuraminic acid.

Silver HK, Murray RN, Worth AJ, Salinas FA, Spinelli JJ. Silver HK, et al. Int J Cancer. 1983 Jan 15;31(1):39-43. doi: 10.1002/ijc.2910310107. Int J Cancer. 1983. PMID: 6832847

3

Nuclear DNA, serum sialic acid and measured depth in malignant melanoma for predicting disease recurrence and survival.

Silver HK, Karim KA, Le Riche J, de Jong G, Spinelli J, Worth A, McLean DI, Gallagher R. Silver HK, et al. Int J Cancer. 1989 Jul 15;44(1):31-4. doi: 10.1002/ijc.2910440106. Int J Cancer. 1989. PMID: 2744894

4

Anatomic distribution of acquired melanocytic nevi in white children. A comparison with melanoma: the Vancouver Mole Study.

Gallagher RP, McLean DI, Yang CP, Coldman AJ, Silver HK, Spinelli JJ, Beagrie M. Gallagher RP, et al. Among authors: silver hk. Arch Dermatol. 1990 Apr;126(4):466-71. Arch Dermatol. 1990. PMID: 2321992

5

Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Similarities to melanoma: the Vancouver Mole Study.

Gallagher RP, McLean DI, Yang CP, Coldman AJ, Silver HK, Spinelli JJ, Beagrie M. Gallagher RP, et al. Among authors: silver hk. Arch Dermatol. 1990 Jun;126(6):770-6. Arch Dermatol. 1990. PMID: 2346321

6

Survival, response and immune effects in a prospectively randomized study of dose strategy for alpha-N1 interferon.

Silver HK, Connors JM, Kong S, Karim KA, Spinelli JJ. Silver HK, et al. Br J Cancer. 1988 Dec;58(6):783-7. doi: 10.1038/bjc.1988.309. Br J Cancer. 1988. PMID: 2975951 Free PMC article. Clinical Trial.

7

Effect of lymphoblastoid interferon on lymphocyte subsets in cancer patients.

Silver HK, Connors JM, Karim KA, Kong S, Spinelli JJ, de Jong G, McLean DM, Salinas FA. Silver HK, et al. J Biol Response Mod. 1983;2(5):428-40. J Biol Response Mod. 1983. PMID: 6644347 Clinical Trial.

8

Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group.

Quirt IC, Shelley WE, Pater JL, Bodurtha AJ, McCulloch PB, McPherson TA, Paterson AH, Prentice R, Silver HK, Willan AR, et al. Quirt IC, et al. Among authors: silver hk. J Clin Oncol. 1991 May;9(5):729-35. doi: 10.1200/JCO.1991.9.5.729. J Clin Oncol. 1991. PMID: 2016615 Clinical Trial.

9

Treatment of advanced malignant melanoma with high dose methotrexate and folinic acid rescue.

Leahy MF, Silver HK, Klimo P, Hall TC. Leahy MF, et al. Among authors: silver hk. Med Pediatr Oncol. 1982;10(2):151-6. doi: 10.1002/mpo.2950100206. Med Pediatr Oncol. 1982. PMID: 7040930 Clinical Trial.

10

Serum sialic acid elevations in malignant melanoma patients.

Silver HK, Rangel DM, Morton DL. Silver HK, et al. Cancer. 1978 Apr;41(4):1497-9. doi: 10.1002/1097-0142(197804)41:4<1497::aid-cncr2820410438>3.0.co;2-9. Cancer. 1978. PMID: 639006

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page